Skip to content

Femoral Arterial Access With Ultrasound Trial

Femoral Arterial Access With Ultrasound Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00667381
Acronym
FAUST
Enrollment
1014
Registered
2008-04-28
Start date
2008-04-30
Completion date
2009-03-31
Last updated
2010-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Catheterization, Peripheral Vascular Disease, Vascular Access Complications

Keywords

Ultrasound guidance, Vascular access, Vascular complications

Brief summary

This study is designed to evaluate the routine use of vascular ultrasound as an aid for proper placement of a femoral arterial sheath during cardiac catheterization and peripheral arterial angiography.

Detailed description

Cardiac catheterization is conventionally performed with femoral arterial access using a combination of arterial pulse palpation, anatomical landmarks, and fluoroscopic landmarks to guide needle insertion. Vascular access complications including hematoma formation, retroperitoneal bleeding, and arterial dissection are the most common types of adverse events associated with cardiac catheterization, and have been associated with insertions above and below the level of the common femoral artery. Real-time ultrasound assistance for central venous catheter placement has been proven in multiple studies to reduce complications, and has been recommended by the Agency for Healthcare Research and Quality as a Top 11 Highly Proven patient safety practice. This recommendation has not yet been extended to arterial access, due to a lack of studies to date. However, ultrasound assistance is licensed for and commonly utilized for arterial access, especially in difficult patients. In a pilot study of 71 procedures performed by the lead researcher, ultrasound guidance was associated with an improved 1st pass success rate (83% vs 47%, p=0.002), reduced risk of accidental venipunctures (0% vs 25%, p=0.002), and greater overall success in common femoral artery cannulation (89% vs 69%, p=0.048) as compared with the fluoroscopic control. This study is a multicenter prospective randomized trial to generalize the above findings with more patients studied, a larger number of operators, and across several centers. Similar to the previous study, the ultrasound will be used real-time to visualize the femoral vein, femoral artery, and needle tract as the needle is inserted, to guide the needle towards the appropriate location in the artery. The time for insertion, number of passes, complications, and position of the insertion catheter on the femoral angiogram will be analyzed in the setting of patient factors including age, body mass index, and presence of peripheral vascular disease.

Interventions

DEVICEReal-time Ultrasound Guidance (Site-Rite 5 or 6 machine)

Real-time ultrasound guidance will be used to aid in femoral artery cannulation. This will occur with a 7 MHz ultrasound probe covered with a sterile cover.

Sponsors

C. R. Bard
CollaboratorINDUSTRY
University of Oklahoma
CollaboratorOTHER
US Department of Veterans Affairs
CollaboratorFED
Long Beach Memorial Medical Center
CollaboratorOTHER
University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults age 18 and over * Patients undergoing left heart catheterization or peripheral arterial angiography from the retrograde femoral approach * Willingness and ability to sign consent form * Scheduled to have procedure performed by operator trained in the ultrasound technique

Exclusion criteria

* Access from a site other than the common femoral artery * Nonpalpable femoral pulses * Creatinine \> 3.0 mg/dl, unless already on dialysis * Prisoners * Pregnant women * Unable or refusal to sign consent form * Patients undergoing emergent cardiac catheterization for ST segment elevation myocardial infarction or unstable acute coronary syndrome * Equipment unavailable

Design outcomes

Primary

MeasureTime frameDescription
Participants With Successful Common Femoral Artery Cannulation, as Determined by Femoral AngiographyImmediately, during procedure.Femoral angiography was performed in 490 control patients and 499 ultrasound patients. In 11 control and 4 ultrasound patients, femoral angiography was either not performed or was inadequate for analysis. These patients were excluded from the primary outcome analysis but included for other analyses. Successful common femoral artery cannulation was defined as sheath insertion above the bifurcation of the common femoral artery and below the origin of the inferior epigastric artery. Unsuccessful sheath insertion was defined as sheath insertion outside of these markers.

Secondary

MeasureTime frameDescription
Time to Successful Sheath Insertion.ImmediateTime was measured from first fluoroscopy of the femoral head (control group), or first application of the ultrasound probe (ultrasound group), until successful sheath insertion. Time was not recorded for 1 control patient, and 1 ultrasound patient, these patients were excluded from this analysis but included for other analyses.
Number of Patients With Accidental Femoral Venipunctures.ImmediateNumber of patients with any femoral venipunctures where an insertion was not intended, i.e. excluding patients with planned right heart catheterization. Multiple accidental venipunctures were not double counted. Number of attempts and venipunctures were not recorded in 1 control and 1 ultrasound patient, so the denominator is 500 control patients and 502 ultrasound patients.
Number of Participants With Vascular ComplicationsImmediate and up to 1 month after procedure.Vascular complications were defined as vessel thrombosis, dissection, blood transfusion, hematoma \> 5cm diameter, unexplained bleeding with a drop in Hgb \>4 g/dL, or access site bleeding with drop in Hgb \>3 g/dL. Outcome was assessed by chart review, and clinical or telephone followup at 30 days. Medical records were adjudicated by a blinded independent review committee.

Other

MeasureTime frameDescription
Number of Patients With Successful Common Femoral Artery Placement, Among Those Patients With High Femoral Artery BifurcationsAt angiogram analysisPatients found to have femoral artery bifurcations occurring over the femoral head were prospectively defined as having a high femoral bifurcation. This subgroup was prespecified for analysis during the trial designed, as it was suspected that operators would have particular difficulty inserting the sheath accurately in this population.

Countries

United States

Participant flow

Recruitment details

Between April 2008 and February 2009, 1014 patients presenting for elective or urgent (but not emergent) cardiac or peripheral catheterization were enrolled.

Pre-assignment details

10 patients (6 control, 4 US) were excluded after randomization but before procedure for no longer meeting the inclusion criteria, including cancellation of the procedure, lack of a dual-trained operator, or change in access site. Baseline and procedural data were not recorded in this group, and these were not included in any analysis.

Participants by arm

ArmCount
Control
The combination of anatomic landmarks and fluoroscopic localization of the femoral head will be used to guide femoral arterial access.
501
Ultrasound
Patients randomized to Ultrasound will have anatomic landmarks checked and real-time ultrasound guidance to aid femoral arterial access.
503
Total1,004

Baseline characteristics

CharacteristicUltrasoundTotalControl
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
230 Participants476 Participants246 Participants
Age, Categorical
Between 18 and 65 years
273 Participants528 Participants255 Participants
Age Continuous63.5 years
STANDARD_DEVIATION 12.4
63.8 years
STANDARD_DEVIATION 11.9
64.2 years
STANDARD_DEVIATION 11.4
Region of Enrollment
United States
503 participants1004 participants501 participants
Sex: Female, Male
Female
132 Participants267 Participants135 Participants
Sex: Female, Male
Male
371 Participants737 Participants366 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
17 / 5017 / 503
serious
Total, serious adverse events
0 / 5010 / 503

Outcome results

Primary

Participants With Successful Common Femoral Artery Cannulation, as Determined by Femoral Angiography

Femoral angiography was performed in 490 control patients and 499 ultrasound patients. In 11 control and 4 ultrasound patients, femoral angiography was either not performed or was inadequate for analysis. These patients were excluded from the primary outcome analysis but included for other analyses. Successful common femoral artery cannulation was defined as sheath insertion above the bifurcation of the common femoral artery and below the origin of the inferior epigastric artery. Unsuccessful sheath insertion was defined as sheath insertion outside of these markers.

Time frame: Immediately, during procedure.

ArmMeasureValue (NUMBER)
ControlParticipants With Successful Common Femoral Artery Cannulation, as Determined by Femoral Angiography408 participants
UltrasoundParticipants With Successful Common Femoral Artery Cannulation, as Determined by Femoral Angiography431 participants
Secondary

Number of Participants With Vascular Complications

Vascular complications were defined as vessel thrombosis, dissection, blood transfusion, hematoma \> 5cm diameter, unexplained bleeding with a drop in Hgb \>4 g/dL, or access site bleeding with drop in Hgb \>3 g/dL. Outcome was assessed by chart review, and clinical or telephone followup at 30 days. Medical records were adjudicated by a blinded independent review committee.

Time frame: Immediate and up to 1 month after procedure.

ArmMeasureValue (NUMBER)
ControlNumber of Participants With Vascular Complications17 participants
UltrasoundNumber of Participants With Vascular Complications7 participants
Secondary

Number of Patients With Accidental Femoral Venipunctures.

Number of patients with any femoral venipunctures where an insertion was not intended, i.e. excluding patients with planned right heart catheterization. Multiple accidental venipunctures were not double counted. Number of attempts and venipunctures were not recorded in 1 control and 1 ultrasound patient, so the denominator is 500 control patients and 502 ultrasound patients.

Time frame: Immediate

ArmMeasureValue (NUMBER)
ControlNumber of Patients With Accidental Femoral Venipunctures.79 participants
UltrasoundNumber of Patients With Accidental Femoral Venipunctures.12 participants
Secondary

Time to Successful Sheath Insertion.

Time was measured from first fluoroscopy of the femoral head (control group), or first application of the ultrasound probe (ultrasound group), until successful sheath insertion. Time was not recorded for 1 control patient, and 1 ultrasound patient, these patients were excluded from this analysis but included for other analyses.

Time frame: Immediate

ArmMeasureValue (MEAN)Dispersion
ControlTime to Successful Sheath Insertion.213 secondsStandard Deviation 194
UltrasoundTime to Successful Sheath Insertion.185 secondsStandard Deviation 175
Other Pre-specified

Number of Patients With Successful Common Femoral Artery Placement, Among Those Patients With High Femoral Artery Bifurcations

Patients found to have femoral artery bifurcations occurring over the femoral head were prospectively defined as having a high femoral bifurcation. This subgroup was prespecified for analysis during the trial designed, as it was suspected that operators would have particular difficulty inserting the sheath accurately in this population.

Time frame: At angiogram analysis

ArmMeasureValue (NUMBER)
ControlNumber of Patients With Successful Common Femoral Artery Placement, Among Those Patients With High Femoral Artery Bifurcations111 participants
UltrasoundNumber of Patients With Successful Common Femoral Artery Placement, Among Those Patients With High Femoral Artery Bifurcations123 participants

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026